Qing K Wang

Title: Innovations and Contributions of Qing K Wang

Introduction

Qing K Wang is a notable inventor based in Shaker Heights, Ohio, recognized for her significant contributions to the field of biomedical research. With a total of three patents to her name, she has made remarkable strides in understanding angiogenesis and genetic disorders.

Latest Patents

One of her latest patents focuses on a gene and protein associated with angiogenesis and endothelial cell-specific apoptosis. This invention provides isolated nucleic acid and amino acid sequences encoding VG5Q, a novel angiogenic growth factor protein with pro-angiogenic activity. The patent details the protein's subcellular localization during tubulogenesis and its expression in endothelial cells, highlighting its potential for diagnosing and treating angiogenesis-mediated diseases. Another significant patent involves KVLQT1, a long QT syndrome gene. This patent discloses the genomic structure, including the sequence of intron/exon junctions for KVLQT1 and KCNE1, which are crucial for understanding long QT syndrome. It also reveals newly found mutations in KVLQT1 that result in this condition, paving the way for better screening and treatment options.

Career Highlights

Qing K Wang has worked with esteemed institutions such as the University of Utah Research Foundation and the Cleveland Clinic Foundation. Her work in these organizations has contributed to advancing medical research and innovation.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Mark T Keating and Mark E Curran, further enhancing her research impact.

Conclusion

Qing K Wang's innovative work in the field of genetics and angiogenesis exemplifies her dedication to advancing medical science. Her patents not only contribute to academic knowledge but also hold the potential for significant clinical applications.